Publication | Open Access
Neoadjuvant nivolumab or nivolumab plus LAG-3 inhibitor relatlimab in resectable esophageal/gastroesophageal junction cancer: a phase Ib trial and ctDNA analyses
95
Citations
34
References
2024
Year
| Year | Citations | |
|---|---|---|
Page 1
Page 1